Literature DB >> 7532426

HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons.

E Harrer1, T Harrer, S Buchbinder, D L Mann, M Feinberg, T Yilma, R P Johnson, B D Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7532426

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  13 in total

1.  Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

Authors:  H Cao; P Kanki; J L Sankalé; A Dieng-Sarr; G P Mazzara; S A Kalams; B Korber; S Mboup; B D Walker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.

Authors:  R A McDonald; D L Mayers; R C Chung; K F Wagner; S Ratto-Kim; D L Birx; N L Michael
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif.

Authors:  M A Altfeld; B Livingston; N Reshamwala; P T Nguyen; M M Addo; A Shea; M Newman; J Fikes; J Sidney; P Wentworth; R Chesnut; R L Eldridge; E S Rosenberg; G K Robbins; C Brander; P E Sax; S Boswell; T Flynn; S Buchbinder; P J Goulder; B D Walker; A Sette; S A Kalams
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.

Authors:  Sama Adnan; Arumugam Balamurugan; Alicja Trocha; Michael S Bennett; Hwee L Ng; Ayub Ali; Christian Brander; Otto O Yang
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

5.  Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  R I Connor; K E Sheridan; C Lai; L Zhang; D D Ho
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.

Authors:  C M Hay; D J Ruhl; N O Basgoz; C C Wilson; J M Billingsley; M P DePasquale; R T D'Aquila; S M Wolinsky; J M Crawford; D C Montefiori; B D Walker
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies.

Authors:  J Iroegbu; M Birk; U Lazdina; A Sönnerborg; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

8.  Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype.

Authors:  M R Betts; J P Casazza; B A Patterson; S Waldrop; W Trigona; T M Fu; F Kern; L J Picker; R A Koup
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.

Authors:  L Deml; A Bojak; S Steck; M Graf; J Wild; R Schirmbeck; H Wolf; R Wagner
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.

Authors:  K Grovit-Ferbas; J Ferbas; V Gudeman; S Sadeghi; M B Goetz; J V Giorgi; I S Chen; W A O'Brien
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.